Bundled strategies against infection after liver transplantation: Lessons from multidrug‐resistant Pseudomonas aeruginosa

Asahi Sato, Toshimi Kaido, Taku Iida, Shintaro Yagi, Koichiro Hata, Hideaki Okajima, Shunji Takakura, Satoshi Ichiyama, Shinji Uemoto – 29 January 2016 – Infection is a life‐threatening complication after liver transplantation (LT). A recent outbreak of multidrug‐resistant Pseudomonas aeruginosa triggered changes in our infection control measures. This study investigated the usefulness of our bundled interventions against postoperative infection after LT.

Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes

Mohammed Eslam, Alessandra Mangia, Thomas Berg, Henry Lik Yuen Chan, William L. Irving, Gregory J. Dore, Maria Lorena Abate, Elisabetta Bugianesi, Leon A. Adams, Mustafa A.M. Najim, Luca Miele, Martin Weltman, Lindsay Mollison, Wendy Cheng, Stephen Riordan, Janett Fischer, Manuel Romero‐Gomez, Ulrich Spengler, Jacob Nattermann, Antony Rahme, David Sheridan, David R. Booth, Duncan McLeod, Elizabeth Powell, Christopher Liddle, Mark W.

The changing face of liver transplantation for acute liver failure: Assessment of current status and implications for future practice

Mhairi C. Donnelly, Peter C. Hayes, Kenneth J. Simpson – 28 January 2016 – The etiology and outcomes of acute liver failure (ALF) have changed since the definition of this disease entity in the 1970s. In particular, the role of emergency liver transplantation has evolved over time, with the development of prognostic scoring systems to facilitate listing of appropriate patients, and a better understanding of transplant benefit in patients with ALF.

Subscribe to